Ömer Fatih Ölmez

Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?

Arife Ulaş, Fahriye Tuğba Köş, Erdem Çubukçu et al. · PubMed · 2015 · 49 citations

Predictive value of the modified Early Warning Score in a Turkish emergency department

Erol Armağan, Yusuf Yılmaz, Ömer Fatih Ölmez et al. · European Journal of Emergency Medicine · 2008 · 44 citations

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Nir Peled, Roni Gillis, Patrizia Froesch et al. · Lung Cancer · 2020 · 29 citations

Ophthalmology, Medicine, Nsclc Patients +6

The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme

Ömer Fatih Ölmez, Erdem Çubukçu, Türkkan Evrensel et al. · Clinical & Translational Oncology · 2013 · 25 citations

Neuro-oncology, Tumor Innervation, Glioblastoma Multiforme +10

The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study

Nadiye Akdeniz, Doğan Uncu, Mevlüde İnanç et al. · International Journal of Colorectal Disease · 2021 · 23 citations · Full text